All Stories

  1. Physical exercise improves cardiovascular function after preeclampsia and reduces the risk of recurrent preeclampsia in the subsequent pregnancy: an echocardiographic prospective cohort study
  2. Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology
  3. Umbilical venous flow and maternal hemodynamics as predictors of impaired fetal growth in gestational diabetes: a prospective study
  4. The impact of maternal cardiovascular status prior to labor on birth outcomes: an observational study
  5. Individualized maternal positioning to optimize cardiac output and placental perfusion
  6. ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction
  7. Maternal hemodynamics in early and late fetal growth restriction
  8. Definition, identification, implications and management of hypodynamic hypertension in pregnancy
  9. Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction
  10. Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications?
  11. Erratum: Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine
  12. Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Preeclampsia and Italian Society of Perinatal Medicine
  13. NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation
  14. Longitudinal hemodynamic evaluation of uncomplicated twin pregnancies according to chorionicity: physiological cardiovascular dysfunction in monochorionic twin pregnancy
  15. The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction
  16. Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies
  17. Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM)
  18. Systemic vascular resistance may influence the outcome of in vitro fertilization
  19. Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction
  20. Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics
  21. Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction
  22. Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study
  23. Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure
  24. Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind?
  25. Friendly help for clinical use of maternal hemodynamics
  26. OC10.05: The “Valensise Radar” to understand the maternal hemodynamic status
  27. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  28. Prevention and Treatment of Fetal Growth Restriction by Influencing Maternal Hemodynamics and Blood Volume
  29. Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True?
  30. Assessment of venous hemodynamics and volume homeostasis during pregnancy: recommendations of the International Working Group on Maternal Hemodynamics
  31. Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth
  32. Maternal hemodynamics early in labor: a possible link with obstetric risk?
  33. Functional testing in pregnancy
  34. Screening for pre‐eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non‐obese patients
  35. Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders
  36. Assessment of arterial function in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics
  37. Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy?
  38. A5. Bed rest reduces maternal total vascular resistance and enhances fetal growth
  39. D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients
  40. F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy?
  41. G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles
  42. G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia
  43. H1. Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent pre-eclampsia
  44. Persistent Maternal Cardiac Dysfunction After Preeclampsia Identifies Patients at Risk for Recurrent Preeclampsia
  45. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia
  46. PRE-ECLAMPSIA: ONE NAME, TWO CONDITIONS – THE CASE FOR EARLY AND LATE DISEASE BEING DIFFERENT
  47. Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications
  48. Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: relationship to placenta-related complications of pregnancy
  49. OC14.06: NO donors and volume expansion added to antihypertensive therapy in gestational hypertension decreases systemic vascular resistance and complications
  50. Early and Late Preeclampsia
  51. OP11.10: Maternal myocardial function in asymptomatic 24 weeks' bilateral notching women
  52. Total Vascular Resistance and Left Ventricular Morphology as Screening Tools for Complications in Pregnancy
  53. Fetal growth restriction and maternal cardiac function
  54. OC216: Treatment with NO donor patches in asymptomatic women with bilateral notch and elevated total vascular resistance
  55. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery
  56. Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension
  57. P10.19: Intrauterine growth restriction and fetal body composition
  58. P10.05: Nitric oxide donors and fluid therapy increase fetal growth in gestational hypertension
  59. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome
  60. P05.28: Can we improve fetal growth acting on maternal cardiac function? A pilot study
  61. Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction
  62. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies
  63. MATERNAL CARDIOVASCULAR HAEMODYNAMICS IN NORMAL AND COMPLICATED PREGNANCIES
  64. Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women
  65. Left Ventricular Concentric Geometry as a Risk Factor in Gestational Hypertension
  66. Nifedipine-induced changes in body composition in hypertensive patients at term
  67. Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function
  68. P217: Does nifedipine improve placental function and fetal growth?
  69. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction
  70. C-peptide and insulin levels at 24–30 weeks’ gestation: an increased risk of adverse pregnancy outcomes?
  71. Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: a pilot study
  72. Maternal Diastolic Dysfunction and Left Ventricular Geometry in Gestational Hypertension
  73. WS12-03Uteroplacental resistances and maternal cardiac function in normal and hypertensive pregnancy: a Doppler and echocardiographic study
  74. Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study
  75. Cardiac Function
  76. Cardiac Dysfunction in Hypertensive Pregnancy